Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Y-MABS THERAPEUTICS, INC.

(YMAB)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on Y-MABS THERAPEUTICS, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) Y-MABS THERAPEUTICS, INC.
Analyst Recommendations on Y-MABS THERAPEUTICS, INC.
06/28Y MABS THERAPEUTICS : HC Wainwright Adjusts Price Target on Y-mAbs Therapeutics to $68 From $70, Maintains Buy R..
MT
05/07Y MABS THERAPEUTICS : BofA Securities Upgrades Y-mAbs Therapeutics to Buy From Neutral; Price Target is $56
MT
04/21Y MABS THERAPEUTICS : Wedbush Adjusts Price Target on Y-mAbs Therapeutics to $52 From $67 on Naxitamab Price Adj..
MT
03/22Y MABS THERAPEUTICS : JP Morgan Raises Price Target for Overweight-Rated Y-mAbs Therapeutics to $52 From $57
MT
03/01Y MABS THERAPEUTICS : HC Wainwright & Co. Adjusts Price Target on Y-mAbs Therapeutics to $70 From $65, Maintains..
MT
02/26Y MABS THERAPEUTICS : Wedbush Lowers Price Target for Y-mAbs Therapeutics to $67 From $71 as Approval for Omburt..
MT
01/15Y MABS THERAPEUTICS : BofA Securities Downgrades Y-mAbs Therapeutics to Neutral From Buy; Price Target is $56
MT
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 26,55 $
Average target price 55,33 $
Spread / Average Target 108%
High Price Target 68,00 $
Spread / Highest target 156%
Low Price Target 41,00 $
Spread / Lowest Target 54,4%
Consensus detail
Consensus revision (last 18 months)